We therefore focused on miR-4728-3p and selected two HER2-positive breast cancer cell lines, SK-BR-3 and BT-474, to block miRNA function by transfecting 2′-O-methyl-modified antisense oligonucleotides (ASOs). Here, ERBB2 is linked to breast carcinoma.